---
figid: PMC11839412__fpubh-13-1509675-g0002
figtitle: Roles of WNT and Notch in CD133+cell cycle regulation (By Figdraw
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11839412
filename: fpubh-13-1509675-g0002.jpg
figlink: /pmc/articles/PMC11839412/figure/F2/
number: F2
caption: The roles of WNT and Notch in CD133+cell cycle regulation (By Figdraw.).
  CD133 directly modulates CSCs' cell cycle through the WNT/β-catenin and Notch signaling
  pathways. In the WNT/β-catenin pathway, EZH2 activates WNT signaling by downregulating
  P21, promoting the G1/S phase transition. Hypoxia-induced GLT8D1 binds CD133 to
  activate WNT signaling and drive tumorigenesis. The WNT inhibitor XAV939 reduces
  CD133 expression and induces G0/G1 phase arrest. In the Notch pathway, Notch regulates
  CD133 via HES1, influencing the cell cycle. Notch inhibition decreases CD133 expression
  and induces G0/G1 arrest. Notch target genes include CCND1, P21, and MYC. TRPM7
  upregulates CD133 and activates Notch signaling, while leptin (LEP) enhances Notch
  receptor expression to promote CD133 and accelerate S phase progression. ALDH1A1
  upregulation inhibits Notch signaling and promotes G1 arrest in lung adenocarcinoma
  stem cells
papertitle: Unveiling the impact of CD133 on cell cycle regulation in radio- and chemo-resistance
  of cancer stem cells
reftext: Luyao Wu, et al. Front Public Health. 2025;13(NA).
year: '2025'
doi: 10.3389/fpubh.2025.1509675
journal_title: Frontiers in Public Health
journal_nlm_ta: Front Public Health
publisher_name: Frontiers Media SA
keywords: malignancy | cancer stem cells | CD133 | radio- and chemo-resistance | cell
  cycle
automl_pathway: 0.9547248
figid_alias: PMC11839412__F2
figtype: Figure
redirect_from: /figures/PMC11839412__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11839412__fpubh-13-1509675-g0002.html
  '@type': Dataset
  description: The roles of WNT and Notch in CD133+cell cycle regulation (By Figdraw.).
    CD133 directly modulates CSCs' cell cycle through the WNT/β-catenin and Notch
    signaling pathways. In the WNT/β-catenin pathway, EZH2 activates WNT signaling
    by downregulating P21, promoting the G1/S phase transition. Hypoxia-induced GLT8D1
    binds CD133 to activate WNT signaling and drive tumorigenesis. The WNT inhibitor
    XAV939 reduces CD133 expression and induces G0/G1 phase arrest. In the Notch pathway,
    Notch regulates CD133 via HES1, influencing the cell cycle. Notch inhibition decreases
    CD133 expression and induces G0/G1 arrest. Notch target genes include CCND1, P21,
    and MYC. TRPM7 upregulates CD133 and activates Notch signaling, while leptin (LEP)
    enhances Notch receptor expression to promote CD133 and accelerate S phase progression.
    ALDH1A1 upregulation inhibits Notch signaling and promotes G1 arrest in lung adenocarcinoma
    stem cells
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HIF1A
  - PROM1
  - GLT8D1
  - EZH2
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - GSK3A
  - GSK3B
  - AXIN1
  - AXIN2
  - APC
  - PROC
  - CTNNB1
  - ALDH1A1
  - HES1
  - GATD3
  - TRPM7
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - CCND1
  - MYC
  - LEP
  - Cancer
---
